Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update

SIMPLE SUMMARY: Immune checkpoint inhibitors are a class of anti-cancer therapy that work by harnessing the body’s immune system to promote cancer cell death. These drugs have become standard of care for many types of cancer, including melanoma and lung cancer, after clinical trials showed they work...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCarli, Kathryn, Strosberg, Jonathan, Almhanna, Khaldoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454768/
https://www.ncbi.nlm.nih.gov/pubmed/36077740
http://dx.doi.org/10.3390/cancers14174201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454768/
https://www.ncbi.nlm.nih.gov/pubmed/36077740
http://dx.doi.org/10.3390/cancers14174201

Ejemplares similares